chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.3
Sex: M
Vaccine: PPV
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a physician concerning a 3 month old male who was vaccinated with a dose of PNEUMOVAX 23 by human error. No adverse effects were reported. Follow up information had been received from a medical assistant through a telephone call indicating that the patient should have been administered PREVNAR instead of PNEUMOVAX 23 (lot # 664871/1142Y). The employee pulled the wrong vaccine out of fridge. The patient was doing well and no adverse effects. No further information is available.
Age: 15.0
Sex: M
Vaccine: MNQ, PPV
Symptoms: Body temperature increased, Cough, Influenza, Influenza A virus test positive, Injection site erythema
Clinical narrative: Information has been received from a medical assistant concerning a 15 year old male with no pertinent medical history and no known allergies, who on 16-OCT-2009 was inadvertently vaccinated with a 0.5ml dose of PNEUMOVAX 23 (lot # 662842/1296X) IM in the right arm, staff error. The patient was in for a sport physical. Suspect therapy included MENACTRA (unspecified) in the left arm. The patient's mother called the doctor office stating child got ill several hours post vaccination on 16-OCT-2009, Friday night. Mom reported that child had high fever, nausea, some vomiting, right arm red, hot, and tender to touch. Same evening child was taken to ER, and seen for a cough. The patient had 101F fever, mild sore throat, and nausea. Nasal test was performed for type A and type B flu. The result was positive for influenza type A. Child was treated with TAMIFLU, ZOFRAN 4 mg, and TYLENOL. The patient was not admitted to hospital, was discharged. The mother stated the patient was "a little better". Follow up information has been received from a medical assistant concerning a 15 year old male with no illness at time of vaccination who on 16-OCT-2009 in the PM was vaccinated with a dose of PNEUMOVAX 23 (lot # 662842/1296X) IM in the right arm deltoid, instead of MENACTRA. The patient also concomitantly received a dose of MENACTRA (lot # 4306IEA) IM in the left arm deltoid in the PM on 16-OCT-2009. The mother stated that the patient became ill with fever and body aches several hours after immunization was given. It was noted that the patient's father had just been diagnosed with influenza type A. The patient required ER room or doctor visit. At time of report, the patient recovered. Follow up information has been received from a medical assistant concerning a 15 year old male with influenza A at time of vaccination, who on 16-OCT-2009 was vaccinated with a dose of PNEUMOVAX 23 (lot # 662842/1296X) IM. On 16-OCT-2009 at pm, the patient had fever and red swelling at site of immunization. Lab test was performed, the patient had influenza A. The patient did not seek medical attention. The outcome was not reported. No further information is available.
Age: 15.0
Sex: M
Vaccine: MNQ, PPV
Symptoms: Injection site pain, Injection site swelling, Injection site warmth, Malaise, Nausea
Clinical narrative: Information has been received from a medical assistant concerning a 15 year old male with no pertinent medical history and no known allergies, who on 16-OCT-2009 was inadvertently vaccinated with a 0.5ml dose of PNEUMOVAX 23 (lot # 662842/1296X) IM in the right arm, staff error. The patient was in for a sport physical. Suspect therapy included MENACTRA (unspecified) in the left arm. The patient's mother called the doctor office stating child got ill several hours post vaccination on 16-OCT-2009, Friday night. Mom reported that child had high fever, nausea, some vomiting, right arm red, hot, and tender to touch. Same evening child was taken to ER, and seen for a cough. The patient had 101F fever, mild sore throat, and nausea. Nasal test was performed for type A and type B flu. The result was positive for influenza type A. Child was treated with TAMIFLU, ZOFRAN 4 mg, and TYLENOL. The patient was not admitted to hospital, was discharged. The mother stated the patient was "a little better". Follow up information has been received from a medical assistant concerning a 15 year old male with no illness at time of vaccination who on 16-OCT-2009 in the PM was vaccinated with a dose of PNEUMOVAX 23 (lot # 662842/1296X) IM in the right arm deltoid, instead of MENACTRA. The patient also concomitantly received a dose of MENACTRA (lot # 4306IEA) IM in the left arm deltoid in the PM on 16-OCT-2009. The mother stated that the patient became ill with fever and body aches several hours after immunization was given. It was noted that the patient's father had just been diagnosed with influenza type A. The patient required ER room or doctor visit. At time of report, the patient recovered. Follow up information has been received from a medical assistant concerning a 15 year old male with influenza A at time of vaccination, who on 16-OCT-2009 was vaccinated with a dose of PNEUMOVAX 23 (lot # 662842/1296X) IM. On 16-OCT-2009 at pm, the patient had fever and red swelling at site of immunization. Lab test was performed, the patient had influenza A. The patient did not seek medical attention. The outcome was not reported. No further information is available.
Age: 15.0
Sex: M
Vaccine: MNQ, PPV
Symptoms: Oropharyngeal pain, Pain, Pyrexia, Vomiting, Wrong drug administered
Clinical narrative: Information has been received from a medical assistant concerning a 15 year old male with no pertinent medical history and no known allergies, who on 16-OCT-2009 was inadvertently vaccinated with a 0.5ml dose of PNEUMOVAX 23 (lot # 662842/1296X) IM in the right arm, staff error. The patient was in for a sport physical. Suspect therapy included MENACTRA (unspecified) in the left arm. The patient's mother called the doctor office stating child got ill several hours post vaccination on 16-OCT-2009, Friday night. Mom reported that child had high fever, nausea, some vomiting, right arm red, hot, and tender to touch. Same evening child was taken to ER, and seen for a cough. The patient had 101F fever, mild sore throat, and nausea. Nasal test was performed for type A and type B flu. The result was positive for influenza type A. Child was treated with TAMIFLU, ZOFRAN 4 mg, and TYLENOL. The patient was not admitted to hospital, was discharged. The mother stated the patient was "a little better". Follow up information has been received from a medical assistant concerning a 15 year old male with no illness at time of vaccination who on 16-OCT-2009 in the PM was vaccinated with a dose of PNEUMOVAX 23 (lot # 662842/1296X) IM in the right arm deltoid, instead of MENACTRA. The patient also concomitantly received a dose of MENACTRA (lot # 4306IEA) IM in the left arm deltoid in the PM on 16-OCT-2009. The mother stated that the patient became ill with fever and body aches several hours after immunization was given. It was noted that the patient's father had just been diagnosed with influenza type A. The patient required ER room or doctor visit. At time of report, the patient recovered. Follow up information has been received from a medical assistant concerning a 15 year old male with influenza A at time of vaccination, who on 16-OCT-2009 was vaccinated with a dose of PNEUMOVAX 23 (lot # 662842/1296X) IM. On 16-OCT-2009 at pm, the patient had fever and red swelling at site of immunization. Lab test was performed, the patient had influenza A. The patient did not seek medical attention. The outcome was not reported. No further information is available.
Age: 60.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Pruritus
Clinical narrative: Information has been received from a pharmacist concerning an "adult" female patient with no known drug allergies who about 10 years ago in approximately 1999 and on 16-OCT-2009 was vaccinated IM with a first and second (lot# 663889/0632Y) 0.5ml doses of PNEUMOVAX 23. On 16-OCT-2009 "within 12 hours of vaccination" the patient experienced pain, swelling, heat, redness and possible bruising at the injection site. The patient did not have fever. The patient was instructed to take BENADRYL and ibuprofen. At the time of the report, the patient was recovering. The patient came to the pharmacy to seek medical attention. No lab diagnostic study was performed. Follow up information has been received from a pharmacist concerning a 60 year old female pharmacy technician with no pertinent medical history and no illness at the time of vaccination who on 27-OCT-2009 (previously reported at 16-OCT-2009), at 11:00 AM was vaccinated IM into her arm with a first (previously reported as second) dose of PNEMOVAX 23 (lot# 665401/1320Y, previously reported as 663889/0632Y). On 27-OCT-2009 the patient's arm was swollen, hot and painful. The patient also had itching (slight). At the time of the report, the patient recovered. This is one of several reports received from the same source. Additional information is not available.
Age: 55.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a licensed practical nurse concerning a 55 year old female patient with allergic to aspirin, statins, NIACIN and REMERON who on 15-OCT-2009 was vaccinated IM in the right deltoid with 'one dose" of PNEUMOVAX 23. Concomitant therapy included FOSAMAX, SPIRIVA, hydrocodone, VALTREX and LOVAZA. On 16-OCT-2009 the patient experienced redness, heat, and swelling at the injection site. The patient sought unspecified medical attention. No lab diagnostic study was performed. On unspecified date, the patient recovered. Additional information has been requested.
Age: 71.0
Sex: F
Vaccine: PPV
Symptoms: Injection site pain, Rash, Urticaria
Clinical narrative: Information has been received from a 71 year old female retired nurse with drug reactions/allergy to shellfish, penicillin, ANCEF, ROCEPHIN, CIPRO, vancomycin, other antibiotics unspecified, morphine, DILAUDID and iodine, who on 01-OCT-2009 was vaccinated subcutaneously with a single dose of PNEUMOVAX 23. Concomitant therapy included VIACTIV SOFT CALCIUM CHEWS, vitamin D (unspecified) and aspirin. The nurse reported that she received PNEUMOVAX 23 and experienced a rash and hives on both arms, stomach and both legs and pain at the injection site. On 04-OCT-2009 the patient recovered from all symptoms. The patient sought medical attention (office visit). No laboratory diagnostics studies were performed. Follow up information has been received from the physician who reported that the patient had a significant allergy to iodine and all antibiotics except erythromycin. On 01-OCT-2009 the patient was vaccinated intramuscularly in the right deltoid with a dose of PNEUMOVAX 23. The patient experienced urticaria and recovered on 03-OCT-2009. No further information is expected.
Sex: U
Vaccine: PPV
Symptoms: Local reaction, Oedema peripheral
Clinical narrative: Information has been received from a physician concerning a patient who on an unknown date was vaccinated with a dose of PNEUMOVAX 23. Subsequently the patient experienced swelling of the whole arm after administration of PNEUMOVAX 23. The patient sought unspecified medical attention. At the time of this report, the outcome of the patient was unknown. The physician also reported that on an unknown date the patient developed a local reaction after administration of a flu vaccine (manufacturer unknown). Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a registered pharmacist concerning a 54 year old female patient with hypothyroidism and no drug reactions or allergies, who on 26-OCT-2009 was vaccinated IM in the left arm with a 0.5 ml first dose of PNEUMOVAX 23 (Lot number 662842/1296X). Concomitant therapy included unspecified thyroid medication. The registered pharmacist reported that the patient developed pain at the injection site of the left upper arm several hours after receiving her first dose of PNEUMOVAX 23. On 27-OCT-2009 the patient developed a 4 inch by 4 inch area of redness and swelling extending from the injection site of the left upper arm down to just above the left elbow. At the time of the report the patient had not recovered. No laboratory tests were performed. The patient sought medical attention at the pharmacy. Additional information has been requested.
Age: 50.0
Sex: M
Vaccine: PPV
Symptoms: Incorrect route of drug administration, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a registered nurse concerning an over 50 year old male with a history of hepatitis c who 2 years ago, was vaccinated with the first dose of PNEUMOVAX 23, and on 27-OCT-2009 received the second dose by intradermal route. On 27-OCT-2009 the patient had a local reaction at injection site. It was red, swollen and hot to touch. Patient also received a tuberculin skin test referred to as PPD skin test on 27-OCT-2009. The patient was seen in office. At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 36.0
Sex: M
Vaccine: PPV
Symptoms: Chest X-ray normal, Disorientation, Laboratory test normal, Myalgia, Pain
Clinical narrative: Information has been received from a registered nurse concerning a patient who was vaccinated with PNEUMOVAX 23 vaccine and experienced adverse events.  The patient had unspecified adverse event and went to the hospital.  Unspecified if patient had been admitted.  Name of the hospital was unspecified.  The patient had sought unspecified medical attention.  At the time of the report, the patient's status was unknown.  Follow up information has been received from a registered nurse concerning a 36 year old male who was vaccinated with a dose of PNEUMOVAX 23 vaccine (lot # 663152/0024Y) IM in the left arm on an unspecified date.  Concomitant therapy included tuberculin purified protein derivative (lot # C3060aa) SC in the right arm on 25-AUG-2009 at 11:24 AM.  The patient had a history of therapy with aspirin for the treatment of throat swelling, ZESTRIL for the treatment of cough, SILENOR for the treatment of rash, and bee sting which increased blood pressure.  On 25-AUG-2009 at 9:15 PM the patient complained of fever at 103F, disorientation, myalgia, and feeling achy.  Lab data included chest x-ray, normal; white blood cells count, not elevated; urinalysis, normal; no Gastrointestinal symptoms.  The patient was discharged to home with recommendation for PCP follow up.  On 26-AUG-2009, the PCP follow up listed that the patient reported that the condition improved when the fever decreased.  The patient required ER visit.  The patient recovered on 26-AUG-2009.  This is one of several reports received from the same source.  No further information is available.
Age: 36.0
Sex: M
Vaccine: PPV
Symptoms: Pyrexia, Urine analysis normal, White blood cell count normal
Clinical narrative: Information has been received from a registered nurse concerning a patient who was vaccinated with PNEUMOVAX 23 vaccine and experienced adverse events.  The patient had unspecified adverse event and went to the hospital.  Unspecified if patient had been admitted.  Name of the hospital was unspecified.  The patient had sought unspecified medical attention.  At the time of the report, the patient's status was unknown.  Follow up information has been received from a registered nurse concerning a 36 year old male who was vaccinated with a dose of PNEUMOVAX 23 vaccine (lot # 663152/0024Y) IM in the left arm on an unspecified date.  Concomitant therapy included tuberculin purified protein derivative (lot # C3060aa) SC in the right arm on 25-AUG-2009 at 11:24 AM.  The patient had a history of therapy with aspirin for the treatment of throat swelling, ZESTRIL for the treatment of cough, SILENOR for the treatment of rash, and bee sting which increased blood pressure.  On 25-AUG-2009 at 9:15 PM the patient complained of fever at 103F, disorientation, myalgia, and feeling achy.  Lab data included chest x-ray, normal; white blood cells count, not elevated; urinalysis, normal; no Gastrointestinal symptoms.  The patient was discharged to home with recommendation for PCP follow up.  On 26-AUG-2009, the PCP follow up listed that the patient reported that the condition improved when the fever decreased.  The patient required ER visit.  The patient recovered on 26-AUG-2009.  This is one of several reports received from the same source.  No further information is available.
Sex: U
Vaccine: PPV
Symptoms: Injected limb mobility decreased, Lymphoedema, Pain, Swelling
Clinical narrative: Information has been received from a pharmacy intern concerning a patient who in 2009, was vaccinated with PNEUMOVAX 23. The pharmacy intern reported that the patient developed local reactions after received PNEUMOVAX 23. It was reported that the reactions involved soreness and swelling that lasted 3 to 5 weeks and that the patient could not lift up the injected arm because of the soreness and had lymphedema. At the time of the report the patient had not recovered. It was unknown if the patient sought medical attention. Additional information has been requested. This is one of several reports received from the same source.
Sex: U
Vaccine: PPV
Symptoms: Local reaction, Pain, Swelling
Clinical narrative: Information has been received from a pharmacy intern concerning a patient who in 1999, was vaccinated with a dose of PNEUMOVAX 23 and in 2009, was vaccinated with a dose of PNEUMOVAX 23. The pharmacy intern reported that the patient developed local reactions after received the second dose of PNEUMOVAX 23. It was reported that the reactions involved soreness and swelling that lasted 3 to 5 weeks. At the time of the report the patient had not recovered. It was unknown if the patient experienced a reaction after the dose given in 1999 and if the patient sought medical attention for the soreness and swelling in 2009. Additional information has been requested. This is one of several reports received from the same source.
Age: 71.0
Sex: M
Vaccine: PPV
Symptoms: Asthenia, Body temperature increased, Chills, Injection site erythema, Injection site pain
Clinical narrative: Information has been received from a Licensed Practical Nurse concerning a 71 year old male with diabetes mellitus insulin-dependent, former cigarette smoker and penicillin allergy and a history of prostate cancer who on 27-OCT-2009 was vaccinated with a dose PNEUMOVAX 23 (lot # 662874/1125X) 0.5ml, intramuscularly into right arm. Concomitant therapy included LIDODERM, hydrocodone, citalopram, metformin, metoprolol, PRILOSEC, pravastatin NA, NORVASC and Diazepam. On 27-OCT-2009 the patient experienced swelling, redness, warmth, pain and tenderness of the right arm, violent chills and he was very weak. He treated himself with TYLENOL and ice. He was examined in the office on 29-OCT-2009. The affected area on his right arm by injection site was 10-12 cm in size. The patient's entire right arm was tender and he had fever 100.1 F. He was treated with cool compresses, TYLENOL, BENADRYL and prednisone. At the time on the report on 29-OCT-2009 the patient had not recovered. There were no laboratory diagnostics studies performed. Follow up information was received from the Licensed Practical Nurse who indicated that the patient was a retired male who on 27-OCT-2009 was vaccinated with the first dose of PNEUMOVAX 23 (lot # 662874/1125X) into his right arm at 09:07 AM. According to the practical nurse, the patient developed redness, swelling and warmth of the right upper arm post injection of PNEUMOVAX 23 without relief of symptoms with ice and TYLNEOL, prednisone to reduce inflammation. The patient sought medical attention by a doctor visit. The patient recovered on 30-OCT-2009. No further information is expected.
Age: 71.0
Sex: M
Vaccine: PPV
Symptoms: Injection site swelling, Injection site warmth, Pyrexia, Tenderness
Clinical narrative: Information has been received from a Licensed Practical Nurse concerning a 71 year old male with diabetes mellitus insulin-dependent, former cigarette smoker and penicillin allergy and a history of prostate cancer who on 27-OCT-2009 was vaccinated with a dose PNEUMOVAX 23 (lot # 662874/1125X) 0.5ml, intramuscularly into right arm. Concomitant therapy included LIDODERM, hydrocodone, citalopram, metformin, metoprolol, PRILOSEC, pravastatin NA, NORVASC and Diazepam. On 27-OCT-2009 the patient experienced swelling, redness, warmth, pain and tenderness of the right arm, violent chills and he was very weak. He treated himself with TYLENOL and ice. He was examined in the office on 29-OCT-2009. The affected area on his right arm by injection site was 10-12 cm in size. The patient's entire right arm was tender and he had fever 100.1 F. He was treated with cool compresses, TYLENOL, BENADRYL and prednisone. At the time on the report on 29-OCT-2009 the patient had not recovered. There were no laboratory diagnostics studies performed. Follow up information was received from the Licensed Practical Nurse who indicated that the patient was a retired male who on 27-OCT-2009 was vaccinated with the first dose of PNEUMOVAX 23 (lot # 662874/1125X) into his right arm at 09:07 AM. According to the practical nurse, the patient developed redness, swelling and warmth of the right upper arm post injection of PNEUMOVAX 23 without relief of symptoms with ice and TYLNEOL, prednisone to reduce inflammation. The patient sought medical attention by a doctor visit. The patient recovered on 30-OCT-2009. No further information is expected.
Age: 70.0
Sex: M
Vaccine: FLUX, PPV
Symptoms: Inappropriate schedule of drug administration, Pain in extremity
Clinical narrative: Information has been received from a physician assistant concerning a 70 year old male patient with drug reactions or allergies reported as none and pertinent medical history reported as none who on 14-OCT-2009 (also reported as 14-JAN-2009) was vaccinated with a second dose of PNEUMOVAX 23 (lot # 662268/1134Y) 0.5ml, intramuscularly. Concomitant therapy included influenza virus vaccine (unspecified) administered on the same day on 14-OCT-2009. On 14-OCT-2009 "the patient received his second dose of PNEUMOVAX 23 earlier than he should have and developed pain in the arm he received the injection". The patient sought medical attention called into the office. On 17-OCT-2009 he recovered from pain in the arm. There were no laboratory diagnostic studies performed. Additional information has been requested.
Age: 43.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a 43 year old female impatient with bipolar disorder, lupus erythematous, diabetes, hypertension, arthritis, regentive joint and disk disease, fatty liver, hypothyroidism, cardiomegaly, penicillin and COMPAZINE allergy who on "29-OCT-2009 or 30-OCT-2009" was vaccinated a dose of PNEUMOVAX 23. Concomitant therapy included CAMPRAL, VISTARIL, BUSPAR, ABILIFY, LAMICTAL, SEROQUEL, AMBIEN, lithiumC03, morphineSO4, DURAGESIC, SKELAXIN, NASONEX, PLAQUENIL, methotrexate, folic acid, prednisone, LYRICA, SALAGEN TABLETS, glimepiride, potassium chloride, BUMEX, TOPROL XL TABLETS, SYNTHROID, lisinopril, fenofibrate, triamcinolone acetonide, NEXIUM, VOLTAREN and MIRENA and an unspecified medication "NUMOISYN". On "31-OCT-2009 or 01-NOV-2009" while she was hospitalized, the patient noticed swelling and hotness around the injection site after receiving PNEUMOVAX 23. The patient also observed redness around the injection site. At the time of reporting the patient had not recovered. Additional information has been requested.
Age: 38.0
Sex: F
Vaccine: PPV, TYP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a nurse practitioner concerning a 38 year old female with no known drug reactions / allergies and no pertinent medical history reported who on 30-OCT-2009 was vaccinated IM with a first dose of PNEUMOVAX 23 in the left deltoid (lot number: 663150/0468Y).  Concomitant vaccine included a dose of typhoid vaccine (unspecified) on 30-OCT-2009 and concomitant therapy included VENTOLIN, ALBUTEROL, ZOLOFT and CLARITIN.  The nurse practitioner reported that on 31-OCT-2009 the patient developed injection site pain, tenderness, injection site redness and injection site swelling after her first dose of PNEUMOVAX 23.  The patient took over the counter unspecified pain relievers to treat her symptoms.  No laboratory test was performed.  At the time of the report the outcome of the patient was recovering.  The patient sought medical attention at the physician's office.  Follow up information has been received from the nurse practitioner concerning the female scientist with asthma, seasonal allergies and scoliosis who on 30-OCT-2009 was vaccinated with a first dose of PNEUMOVAX 23 (Lot No. 662842/1296X, previously reported as 663150/0468Y) in the left deltoid).  Concomitant vaccination on the same day included a first dose of TYPHIM VI (Lot No. E0213) on her right deltoid.  There was no illness at the time of vaccination.  It was also reported that the patient was also vaccinated with a first dose of BOOSTRIX (Lot No. AC52B039AA) on her right deltoid on 28-OCT-2009.  On 31-OCT-2009, the patient developed swelling and erythema at the injection site with tenderness.  Subsequently, a follow-up conversation on 24-NOV-2009 reported that the patient recovered.  Follow up information has been received from the nurse practitioner concerning the female patient with reactive airway disease and asthma and no illness at the time of vaccination who on 30-OCT-2009 was vaccinated with a first dose of PNEUMOVAX 23.  On 31-OCT-2009 the patient developed soreness and tenderness at the site of injection.  No treatment was given, just recommended OTC analgesics and warm soaks.  No further information is available.
Sex: F
Vaccine: PPV
Symptoms: Hypersensitivity
Clinical narrative: Information has been received from a female consumer who on an unspecified date was vaccinated with a dose of PNEUMOVAX 23. Subsequently, on an unspecified date the patient experienced an allergic reaction to PNEUMOVAX 23. It was unknown if the patient sought medical attention. At the time of the report, the outcome of the event was unknown. No further information is available.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Injection site pain, Injection site reaction, Musculoskeletal stiffness
Clinical narrative: Information has been received from a registered nurse concerning a patient who was vaccinated with PNEUMOVAX 23 and experienced adverse events. The patient had injection site reaction that looked like cellulitis. The patient had sought unspecified medical attention. At the time of the report, the patient's status was unknown. Follow up information received from a registered nurse indicating that the 65 year old female patient with no illness at time of vaccination and no known drug allergies, on 04-SEP-2009 at 9:34 am was vaccinated with a dose of PNEUMOVAX 23 (lot # 662598/0466Y) IM in the left arm. Subsequently, on the same day the patient experienced site pain and "arm feels stiff". There were no breathing difficulties, no fever and no redness or swelling at site. The patient "felt better today (05-SEP-2009) than yesterday". There were no labs and diagnostic tests performed. The patient recovered on an unknown date. This is one of several reports received from the same source. No further information is available.
Sex: U
Vaccine: PPV
Symptoms: Cellulitis, Cough, Myalgia, Nasopharyngitis, Pyrexia
Clinical narrative: Information has been received from a certified medical assistant concerning 12 patients who on an unknown date were vaccinated with a dose of PNEUMOVAX 23 (Lot number: 663888/0627Y or 662599/1076X). The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 ranging from fevers of 102F to 103F and cellulitis." Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given". At the time of the report the patient's outcome were not reported. The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital. The other patients sought medical attention at the physician's office. Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office. Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never had reactions such as this in their office". Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified). On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23. This is one of several reports received from the same source.
Sex: U
Vaccine: PPV
Symptoms: Upper respiratory tract congestion
Clinical narrative: Information has been received from a certified medical assistant concerning 12 patients who on an unknown date were vaccinated with a dose of PNEUMOVAX 23 (Lot number: 663888/0627Y or 662599/1076X). The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 ranging from fevers of 102F to 103F and cellulitis." Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given". At the time of the report the patient's outcome were not reported. The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital. The other patients sought medical attention at the physician's office. Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office. Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never had reactions such as this in their office". Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified). On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23. This is one of several reports received from the same source.
Sex: U
Vaccine: PPV
Symptoms: Cellulitis, Cough, Influenza like illness, Myalgia, Pyrexia
Clinical narrative: Information has been received from a certified medical assistant concerning 12 patients who on an unknown date were vaccinated with a dose of PNEUMOVAX 23 (Lot number: 663888/0627Y or 662599/1076X). The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 ranging from fevers of 102F to 103F and cellulitis". Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given". At the time of the report the patient's outcome were not reported. The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital. The other patients sought medical attention at the physician's office. Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office. Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never had reactions such as this in their office". Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified). On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23. This is one of several reports received from the same source.
Sex: U
Vaccine: PPV
Symptoms: Respiratory tract congestion
Clinical narrative: Information has been received from a certified medical assistant concerning 12 patients who on an unknown date were vaccinated with a dose of PNEUMOVAX 23 (Lot number: 663888/0627Y or 662599/1076X). The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 ranging from fevers of 102F to 103F and cellulitis". Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given". At the time of the report the patient's outcome were not reported. The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital. The other patients sought medical attention at the physician's office. Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office. Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never had reactions such as this in their office". Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified). On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23. This is one of several reports received from the same source.
Sex: U
Vaccine: PPV
Symptoms: Cellulitis, Cough, Immunisation reaction, Myalgia, Nasopharyngitis
Clinical narrative: Information has been received from a certified medical assistant concerning 12 patients who on an unknown date were vaccinated with a dose of PNEUMOVAX 23 (Lot number: 663888/0627Y or 662599/1076X). The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 ranging from fevers of 102F to 103F and cellulitis". Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given". At the time of the report the patient's outcome were not reported. The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital. The other patients sought medical attention at the physician's office. Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office. Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never had reactions such as this in their office". Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified). On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23. This is one of several reports received from the same source.
Sex: U
Vaccine: PPV
Symptoms: Pyrexia, Respiratory tract congestion, Vaccination complication
Clinical narrative: Information has been received from a certified medical assistant concerning 12 patients who on an unknown date were vaccinated with a dose of PNEUMOVAX 23 (Lot number: 663888/0627Y or 662599/1076X). The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 ranging from fevers of 102F to 103F and cellulitis". Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given". At the time of the report the patient's outcome were not reported. The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital. The other patients sought medical attention at the physician's office. Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office. Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never had reactions such as this in their office". Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified). On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23. This is one of several reports received from the same source.
Sex: U
Vaccine: PPV
Symptoms: Respiratory tract congestion, Vaccination complication
Clinical narrative: Information has been received from a certified medical assistant concerning 12 patients who on an unknown date were vaccinated with a dose of PNEUMOVAX 23 (Lot number: 663888/0627Y or 662599/1076X). The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 ranging from fevers of 102F to 103F and cellulitis". Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given". At the time of the report the patient's outcome were not reported. The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital. The other patients sought medical attention at the physician's office. Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office. Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never had reactions such as this in their office". Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified). On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23. This is one of several reports received from the same source.
Sex: U
Vaccine: PPV
Symptoms: Cellulitis, Cough, Myalgia, Nasopharyngitis, Pyrexia
Clinical narrative: Information has been received from a certified medical assistant concerning 12 patients who on an unspecified date were vaccinated with a dose of PENUMOVAX 23 (Lot number: 663888/0627Y or 662599/1076X). The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 ranging from fevers of 102F to 103F and cellulitis." Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given". At the time of the report the patient's outcome were not reported. The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital. The other patients sought medical attention at the physician's office. Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office. Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never had reactions such this in their office". Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified). On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23. This is one of several reports received from the same source.
Sex: U
Vaccine: PPV
Symptoms: Respiratory tract congestion
Clinical narrative: Information has been received from a certified medical assistant concerning 12 patients who on an unspecified date were vaccinated with a dose of PENUMOVAX 23 (Lot number: 663888/0627Y or 662599/1076X). The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 ranging from fevers of 102F to 103F and cellulitis." Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given". At the time of the report the patient's outcome were not reported. The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital. The other patients sought medical attention at the physician's office. Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office. Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never had reactions such this in their office". Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified). On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23. This is one of several reports received from the same source.
Sex: U
Vaccine: PPV
Symptoms: Cellulitis, Cough, Myalgia, Nasopharyngitis, Pyrexia
Clinical narrative: Information has been received from a certified medical assistant concerning 12 patients who on an unknown date were vaccinated with a dose of PNEUMOVAX 23 (Lot number 662599/1076X). The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 from fevers of 102F to 103F and cellulitis." Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given". At the time of the report the patient's outcome were not reported. The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital. The other patients sought medical attention at the physician's office. Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office. Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never had reactions such as this in their office". Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified). On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23. This is one of several reports received from the same source.
Sex: U
Vaccine: PPV
Symptoms: Upper respiratory tract congestion
Clinical narrative: Information has been received from a certified medical assistant concerning 12 patients who on an unknown date were vaccinated with a dose of PNEUMOVAX 23 (Lot number 662599/1076X). The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 from fevers of 102F to 103F and cellulitis." Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given". At the time of the report the patient's outcome were not reported. The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital. The other patients sought medical attention at the physician's office. Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office. Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never had reactions such as this in their office". Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified). On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23. This is one of several reports received from the same source.
Sex: U
Vaccine: PPV
Symptoms: Cellulitis, Cough, Myalgia, Nasopharyngitis, Pyrexia
Clinical narrative: Information has been received from a certified medical assistant concerning 12 patients who on an unknown date were vaccinated with a dose of PNEUMOVAX 23 (Lot numbe: 663888/0627Y or 662599/1076X). The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 ranging form fevers to 102F to 103F and cellulitis". Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given". At the time of the report the patient's outcome were not reported. The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital. The other patients sought medical attention at the physician's office. Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office. Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never had reactions such as this in their office". Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified). On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23. This is one of several reports received from the same source.
Sex: U
Vaccine: PPV
Symptoms: Upper respiratory tract congestion
Clinical narrative: Information has been received from a certified medical assistant concerning 12 patients who on an unknown date were vaccinated with a dose of PNEUMOVAX 23 (Lot numbe: 663888/0627Y or 662599/1076X). The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 ranging form fevers to 102F to 103F and cellulitis". Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given". At the time of the report the patient's outcome were not reported. The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital. The other patients sought medical attention at the physician's office. Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office. Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never had reactions such as this in their office". Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified). On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23. This is one of several reports received from the same source.
Sex: U
Vaccine: PPV
Symptoms: Cellulitis, Cough, Myalgia, Nasopharyngitis, Pyrexia
Clinical narrative: Information has been received from a certified medical assistant concerning 12 patients who on an unknown date were vaccinated with a dose of PNEUMOVAX 23 (Lot number: 663888/0627Y or 662599/1076X).  The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 ranging from fevers to 102F to 103F and cellulitis."  Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given".  At the time of the report the patient's outcome were not reported.  The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital.  The other patients sought medical attention at the physician's office.  Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office.  Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never reactions such as this in their office".  Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified).  On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23.  This is one of several reports received from the same source.